Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2022 (2)
  • 2021 (7)
  • 2020 (1)
  • 2019 (1)

Subject

  • Drug Trafficking (68)
  • Arrests/Convictions - Major (60)
  • Overdose (42)
  • Fake Pills (25)
  • Guns/Weapons (24)
  • Prescription Drugs (21)
  • OCDETF/Task Force (20)
  • Guilty Plea (18)
  • Major Law Enforcement Operation (13)
  • Synthetic drugs (13)
  • Seizures (Drugs/Property) (12)
  • Take Back Day (12)
  • Extraditions (10)
  • Money Laundering (10)
  • Diversion Division (8)
  • Outreach/Drug Prevention (8)
  • One Pill Can Kill (6)
  • Task Forces/Task Force Officers (5)
  • International/Foreign Operations (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Gangs (3)
  • Press Conferences (3)
  • HIDTA (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • Fentanyl Awareness (1)
  • Fentanyl Free America (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Red Ribbon (1)
  • Scam Calls (1)
  • Pharmaceuticals/Pharmacists/Physicians (13)

Drug Name

  • Opioids (2)
  • Fentanyl (1)
  • Oxycodone (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (9)
  • Sede (9)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • Dallas (8)
  • San Diego (5)
Clear All Results
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

Junio 27, 2024
SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
Junio 27, 2024
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

Junio 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
Junio 03, 2024
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

San Diego Pharmacy Pays $105,000 Penalty for Illegitimately Dispensing Opioids

Enero 20, 2022
SAN DIEGO – San Diego’s Balboa Pharmacy has paid $105,000 to resolve allegations that it illegally dispensed opioids and other dangerous drugs to its patients, according to a settlement agreement signed by Balboa Pharmacy and the United States. The settlement stems from the United States’ continued efforts to combat the...
Enero 20, 2022
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Noviembre 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
Noviembre 30, 2021
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

Octubre 21, 2021
DALLAS– The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published by the...
Octubre 21, 2021
PRESS RELEASE

National Health Care Fraud Enforcement Action Results in Charges Involving over $1.4 Billion in Alleged Losses

Septiembre 21, 2021
DALLAS – The Department of Justice announced today criminal charges against 138 defendants, including 42 doctors, nurses, and other licensed medical professionals, in 31 federal districts across the United States, for their alleged participation in various healthcare fraud schemes that resulted in approximately $1.4 billion in alleged losses. The charges...
Septiembre 21, 2021
PRESS RELEASE

San Diego Doctor Pays $200,000 to Resolve Allegations that He Wrote Illegitimate Opioid Prescriptions

Septiembre 02, 2021
SAN DIEGO – San Diego area pain clinic doctor Brenton Wynn, M.D., has paid $200,000 to resolve allegations that he illegally prescribed opioids and other dangerous drugs to his patients, according to a settlement agreement signed by Dr. Wynn and the United States. The settlement stems from the United States’...
Septiembre 02, 2021
PRESS RELEASE

Ohio Man Sentenced for Distributing Counterfeit Pharmaceuticals in Dallas

Julio 21, 2021
DALLAS – An Ohio man has been sentenced to federal prison for drug trafficking violations in the Eastern District of Texas, announced today by Eduardo A. Chavez, Special Agent in Charge of DEA Dallas. Austin Seymour, 26, of Uniontown, Ohio, pleaded guilty on Jan. 26, 2021, to conspiracy to distribute...
Julio 21, 2021
PRESS RELEASE

Arlington Doctor and Nurse Practitioner Found Guilty of Operating a Pill Mill

Julio 07, 2021
DALLAS - An Arlington physician has been convicted of drug crimes, announced today by DEA Dallas Special Agent in Charge Eduardo A. Chávez Following five days of trial, a federal jury convicted physician Clinton Battle, 68, of one count of conspiracy to distribute controlled substances and one count of distribution...
Julio 07, 2021
Showing 1 - 10 of 13 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster